We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
Our Scientific Leadership Team reviews every new protocol at the bid stage to assess the potential study risks, and works directly with the Sponsor as well as the CRO Project Teams to mitigate them in advance of FPI and then continues to be available throughout the life of the trial. Every Lotus Study is assigned a Scientific Leadership Team member from this list of Clinicians, Research Experts, and Scientists.
Lotus is a science-driven, full-service CRO with a number of unique qualities that no other CRO can provide. One particular differentiator is that we are under common ownership with Evolution Research Group (ERG), which is a clinical site organization with 20+ wholly-owned clinical research sites around the US.
Because of this connection to ERG, Lotus’ Sponsors benefit from one-stop shopping for:
Today, Lotus Clinical Research announced it has entered into a strategic partnership with Trialogics to strengthen their existing relationship and expand Lotus’ use of Trialogics’ clinical trial software offerings.
We are delighted to announce that our Vice President of Clinical Development, Erin Tireman, Psy.D, will now be overseeing medical writing services as an expansion of her current leadership role within Lotus’ Scientific Services division.
Fast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup time — Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva..
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
